Second line lopinavir/ritonavir monotherapy was inferior to tenofovir/lamivudine/lopinavir/ritonavir in patients who failed NNRTI-regimen: HIV STAR study
Year: 2011
Type: article
Source: F1000Research
Authors: Torsak Bunupuradah, Ploenchan Chetchotisakd, Jintanat Ananworanich, Warangkana Munsakul, Supannee Jirajariyavet, Pacharee Kantipong, Wisit Prasithsirikul, Somnuek Sungkanuparph, Chureeratana Bowonwatanuwong, Virat Klinbuayaem, Bernard Hirschel, Sorakij Bhakeecheep, Kiat Ruxrungtham, Hiv Star study team
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W1774863917
